| Chronic hepatitis B ASF Lok, BJ McMahon Hepatology 45 (2), 507-539, 2007 | 7954* | 2007 |
| A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C CT Wai, JK Greenson, RJ Fontana, JD Kalbfleisch, JA Marrero, ... Hepatology 38 (2), 518-526, 2003 | 5511 | 2003 |
| Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance NA Terrault, ASF Lok, BJ McMahon, KM Chang, JP Hwang, MM Jonas, ... Hepatology 67 (4), 1560-1599, 2018 | 5138 | 2018 |
| EASL clinical practice guidelines: management of chronic hepatitis B virus infection European Association For The Study Of The Liver Journal of hepatology 57 (1), 167-185, 2012 | 3354 | 2012 |
| Hepatitis B virus infection C Trépo, HLY Chan, A Lok The Lancet 384 (9959), 2053-2063, 2014 | 2183 | 2014 |
| A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B TT Chang, RG Gish, R De Man, A Gadano, J Sollano, YC Chao, AS Lok, ... New England Journal of Medicine 354 (10), 1001-1010, 2006 | 2088 | 2006 |
| Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B CL Lai, D Shouval, AS Lok, TT Chang, H Cheinquer, Z Goodman, ... New England Journal of Medicine 354 (10), 1011-1020, 2006 | 1702 | 2006 |
| Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection MS Sulkowski, DF Gardiner, M Rodriguez-Torres, KR Reddy, ... New England Journal of Medicine 370 (3), 211-221, 2014 | 1645 | 2014 |
| Chronic hepatitis B ASF Lok, BJ McMahon Hepatology 34 (6), 1225-1241, 2001 | 1477 | 2001 |
| Management of hepatitis B: 2000—summary of a workshop AS Lok, EJ Heathcote, JH Hoofnagle Gastroenterology 120 (7), 1828-1853, 2001 | 1383 | 2001 |
| Long-term safety of lamivudine treatment in patients with chronic hepatitis B ASF Lok, CL Lai, N Leung, GB Yao, ZY Cui, ER Schiff, JL Dienstag, ... Gastroenterology 125 (6), 1714-1722, 2003 | 1217 | 2003 |
| National Institutes of Health consensus development conference statement: management of hepatitis C National Institutes of Health Hepatology 36 (1), 5, 2002 | 1118* | 2002 |
| Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy: report of a prospective study ASF Lok, RHS Liang, EKW Chiu, KL Wong, TK Chan, D Todd Gastroenterology 100 (1), 182-188, 1991 | 1096 | 1991 |
| Management of hepatitis B: summary of a clinical research workshop JH Hoofnagle, E Doo, TJ Liang, R Fleischer, ASF Lok Hepatology 45 (4), 1056-1075, 2007 | 1081 | 2007 |
| α-fetoprotein, des-γ carboxyprothrombin, and lectin-bound α-fetoprotein in early hepatocellular carcinoma JA Marrero, Z Feng, Y Wang, MH Nguyen, AS Befeler, LR Roberts, ... Gastroenterology 137 (1), 110-118, 2009 | 981 | 2009 |
| Chronic hepatitis B: update of recommendations ASF Lok, BJ McMahon Hepatology 39 (3), 857-861, 2004 | 903 | 2004 |
| Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005 HJ Yim, ASF Lok Hepatology 43 (S1), S173-S181, 2006 | 855 | 2006 |
| Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease AS Lok, LB Seeff, TR Morgan, AM Di Bisceglie, RK Sterling, TM Curto, ... Gastroenterology 136 (1), 138-148, 2009 | 850 | 2009 |
| NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States JA Marrero, RJ Fontana, GL Su, HS Conjeevaram, DM Emick, AS Lok Hepatology 36 (6), 1349-1354, 2002 | 840 | 2002 |
| Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort JA Marrero, RJ Fontana, A Barrat, F Askari, HS Conjeevaram, GL Su, ... Hepatology 41 (4), 707-715, 2005 | 828 | 2005 |
